Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Mann

Showing results (1021-1030 of 1,096) with videos related to

Pageof 110
Sort By:
FEBS Letters|March 23, 2016
Novel autophosphorylation sites of Src family kinases regulate kinase activity and SH2 domain-binding capacityMarion E Weir, Jacqueline E Mann, Thomas Corwin, et al.
The New England Journal of Medicine|December 3, 2015
Intensive Supportive Care plus Immunosuppression in IgA NephropathyThomas Rauen, Frank Eitner, Christina Fitzner, et al.
Journal of Hypertension|February 9, 2021
Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular riskMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2010
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trialFernando Carrera, Charmaine E Lok, Angel de Francisco, et al.
Diabetes, Obesity & Metabolism|June 15, 2026
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE TrialJanet B McGill, Jennifer B Green, Hiddo J L Heerspink, et al.
Diabetes|June 21, 2019
Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the VasculatureIvan Hernandez-Diaz, Jiaqi Pan, Carlo Alberto Ricciardi, et al.
Cardiovascular Diabetology|January 21, 2022
Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular riskMichael Böhm, Helmut Schumacher, Christian Werner, et al.
Diabetes, Obesity & Metabolism|March 22, 2023
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trialDarren K McGuire, Rodica P Busui, John Deanfield, et al.
Science Advances|December 17, 2019
The polar regions in a 2°C warmer worldEric Post, Richard B Alley, Torben R Christensen, et al.
Infection and Immunity|June 8, 2011
Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection modelMatthew S Byrd, Bing Pang, Wenzhou Hong, et al.
Pageof 110

Showing results (1021-1030 of 1,096) with videos related to

Sort By:
Pageof 110
FEBS Letters|March 23, 2016
Novel autophosphorylation sites of Src family kinases regulate kinase activity and SH2 domain-binding capacityMarion E Weir, Jacqueline E Mann, Thomas Corwin, et al.
The New England Journal of Medicine|December 3, 2015
Intensive Supportive Care plus Immunosuppression in IgA NephropathyThomas Rauen, Frank Eitner, Christina Fitzner, et al.
Journal of Hypertension|February 9, 2021
Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular riskMichael Böhm, Helmut Schumacher, Koon K Teo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 5, 2010
Maintenance treatment of renal anaemia in haemodialysis patients with methoxy polyethylene glycol-epoetin beta versus darbepoetin alfa administered monthly: a randomized comparative trialFernando Carrera, Charmaine E Lok, Angel de Francisco, et al.
Diabetes, Obesity & Metabolism|June 15, 2026
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE TrialJanet B McGill, Jennifer B Green, Hiddo J L Heerspink, et al.
Diabetes|June 21, 2019
Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the VasculatureIvan Hernandez-Diaz, Jiaqi Pan, Carlo Alberto Ricciardi, et al.
Cardiovascular Diabetology|January 21, 2022
Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular riskMichael Böhm, Helmut Schumacher, Christian Werner, et al.
Diabetes, Obesity & Metabolism|March 22, 2023
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trialDarren K McGuire, Rodica P Busui, John Deanfield, et al.
Science Advances|December 17, 2019
The polar regions in a 2°C warmer worldEric Post, Richard B Alley, Torben R Christensen, et al.
Infection and Immunity|June 8, 2011
Direct evaluation of Pseudomonas aeruginosa biofilm mediators in a chronic infection modelMatthew S Byrd, Bing Pang, Wenzhou Hong, et al.
Pageof 110